Empowering Intraoperative Visualization
Gleolan® is a real time real intra-operative imaging agent that assists surgeons by improving the visualization of Glioblastoma tumors during resection.
Enabling Selectivity: Visualizing What Counts
Over 40,000 patients in 34 countries (excluding the U.S.) have had tumor resections enhanced by the use of Gleolan®. NXDC is preparing a new drug application with the FDA to bring this exciting product to patients in the United States. Today over 70 prominent neurosurgeons have completed the necessary training to use Gleolan® and fluorescent guided surgery with the goal of improving their patient outcomes.